DIA 2024 Global Annual Meeting

Attending this event?

DIA 2024 Global Annual Meeting

11:00am PDT

#105: The Intersection of Science, Ethics, and Participant Collaboration in Pediatric Rare Disease Product Development Room 17AB

2:15pm PDT

#135: Enhancing the Science of Patient Engagement and Patient Input: What's in the Future? Room 6B #137: Options to Consider When Balancing Risk, Timelines, Cost, and Patient Centricity While Meeting Project Optimus Guidelines Room 1AB

3:30pm PDT

#149: Effective Patient / Industry Collaboration: Valuing Patient Lived Experience To Inform Trial Design Room 6F

8:00am PDT

#206: Early Engagement to Enhance the Incorporation of Patient Experience Data in Drug Development Programs and Regulatory Decision-Making Room 16AB

10:00am PDT

#226: Effective Patient Engagement in Patient Experience Data: Practical Insights from Case Studies in Hard-to-Reach Populations Room 15AB #221: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology Room 6F

1:15pm PDT

#250: Implementable Approaches to Fully Integrating Patient Engagement Across an Entire Company: Including all Clinical Trials Room 2 #246: The State of Clinical Trials in 2024: Are We Making the Grade? Room 11AB

3:15pm PDT

#268: Strategies to Make your Clinical Trials More Inclusive for Patients with Disabilities Room 2 #264: Advancing Innovation in Clinical Trial Design and Conduct Room 6A

4:30pm PDT

#282: Shame and Blame: Our Words are a Barrier to Clinical Research are a Care Option Room 15AB #279: Accelerating Innovation Through Design: Integrating Real-World Data into Clinical Trials Room 6F

8:00am PDT

#306: Which Clinical Outcome Assessment to Choose: Questionnaire or Sensor? Time to Align an Endpoint Selection Framework Room 15AB #302: Have a Safe Trip: Clinical and Patient Alignment in Clinical Trials with Psychedelics Room 6A

10:00am PDT

#321: The ChatBot Will See You Now: Ethical Considerations in Incorporating AI into Informed Consent Room 7AB #318: Defining an Inclusive Clinical Trials Approach in Europe Room 6F #323: Driving Capacity Building, Equity, and Geographic Expansion in Clinical Trials Room 2 #326: Bringing Transformational Treatments to Patients: Regulatory Convergence and Reliance on Cell and Gene Therapy Products Room 6C

11:45am PDT

#332 CH: Informing Clinical Trials with Patient Feedback Through Simulations: An Innovative Methodology Content Hub Sails Pav

1:15pm PDT

#348: Challenges and Solutions to Building the Right Patient-Centered Evidence to Support Fit-For-Purpose Sensor-Based Outcomes Room 2 #350: ICH Efforts to Incorporate Patient’s Perspective to Enhance Quality, Relevance, Safety and Efficacy of Drug Development Room 11AB

2:15pm PDT

#356 RT: Roundtable Discussion: The Chatbot Will See You Now - Ethical Considerations in Incorporating AI in Informed Consent Ballroom 20 A/ Zone 1

3:15pm PDT

#366: The Intersection of Patient-Experience Data and Benefit-Risk Analysis Room 5AB

4:30pm PDT

#373: Patient-Centric Approaches in Summaries and Data Return Room 6D #371: Using Influencers to Recruit Hard-to-Engage Populations Room 7AB

8:00am PDT

#403: Achieving Diversity in Clinical Research Using Digital Health Technologies Room 5AB #405: The FDA's Commitment to Patient-Centric Research: Key Themes from Decentralized Trial Draft Guidance Room 6A #406: More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier Room 6B #408: Targeting Hope for Oncology Patients: Perceptions and Considerations for Genetic Testing and Precision Medicine Room 6D #409: Dive into the Power of Diversity: Leveraging Transferable Skills from Regulated Industries to Regulatory Agencies in Medicines Development Room 2

9:15am PDT

#410: The Impact of Racial Discrimination on the Patient Clinical Trial Experience Room 1AB